TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Beactica Therapeutics AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
4,960
|
4,906
|
3,250 |
Financial expenses |
74
|
73
|
103 |
Earnings before taxes |
-6,058
|
-7,117
|
-7,416 |
EBITDA |
-5,872
|
-6,910
|
-6,922 |
Total assets |
20,131
|
24,395
|
20,609 |
Current assets |
2,872
|
8,604
|
4,815 |
Current liabilities |
1,591
|
2,888
|
3,524 |
Equity capital |
18,214
|
20,805
|
15,778 |
- share capital |
240
|
225
|
216 |
Employees (average) |
9
|
8
![]() |
8 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
90.5%
|
85.3%
|
76.6% |
Turnover per employee |
551
|
613
|
406 |
Profit as a percentage of turnover |
-122.1%
|
-145.1%
|
-228.2% |
Return on assets (ROA) |
-29.7%
|
-28.9%
|
-35.5% |
Current ratio |
180.5%
|
297.9%
|
136.6% |
Return on equity (ROE) |
-33.3%
|
-34.2%
|
-47.0% |
Change turnover |
30
|
1,919
|
1,111 |
Change turnover % |
1%
|
64%
|
52% |
Chg. No. of employees |
1
|
0
![]() |
0 |
Chg. No. of employees % |
13%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.